SILEXION THERAPEUTICS CORP Income Tax Expense
SILEXION THERAPEUTICS CORP (SLXN) reported Income Tax Expense of $3.00 thousand for the 12-month period ending 2025-12-31, per its S-1/A filed 2026-08-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-14
- SILEXION THERAPEUTICS CORP income tax expense (benefit) for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- SILEXION THERAPEUTICS CORP income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- SILEXION THERAPEUTICS CORP income tax expense (benefit) for the quarter ending 2025-06-30 was $3.00K, a 50.00% increase year-over-year.
- SILEXION THERAPEUTICS CORP income tax expense (benefit) for the quarter ending 2024-12-31 was $1.00K, a 83.33% decline year-over-year.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $3.00K derived: sum of 3 quarters · filed 2026-08-14 | $3.00K S-1/A · filed 2026-08-10 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $3.00K derived: sum of 2 quarters · filed 2026-08-14 | $3.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $3.00K 10-Q · filed 2026-08-14 | $3.00K 10-Q · filed 2026-08-14 | ||
| 2024-12-31 | $1.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $3.00K derived: sum of 2 quarters · filed 2026-08-10 | $5.00K derived: sum of 3 quarters · filed 2026-08-10 | $10.00K S-1/A · filed 2026-08-10 |
| 2024-09-30 | $2.00K 10-Q · filed 2025-11-12 | $4.00K derived: sum of 2 quarters · filed 2025-11-12 | $9.00K 10-Q · filed 2025-11-12 | $15.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $2.00K 10-Q · filed 2025-08-12 | $7.00K 10-Q · filed 2025-08-12 | $13.00K derived: sum of 3 quarters · filed 2025-08-20 | $19.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2024-03-31 | $5.00K 10-Q · filed 2025-05-13 | $11.00K derived: sum of 2 quarters · filed 2025-08-20 | $17.00K derived: sum of 3 quarters · filed 2025-08-20 | $27.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2023-12-31 | $6.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-08-20 | $12.00K derived: sum of 2 quarters · filed 2025-08-20 | $22.00K derived: sum of 3 quarters · filed 2025-08-20 | $32.00K 8-K · filed 2025-08-20 |
| 2023-09-30 | $6.00K 10-Q · filed 2024-11-14 | $16.00K derived: sum of 2 quarters · filed 2024-11-14 | $26.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $10.00K 10-Q · filed 2024-08-29 | $20.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |